Lin Yuan: The aging population will benefit traditional Chinese medicine brands
Recently, Lin Yuan, Chairman of Shenzhen Linyuan Investment Management Co., Ltd. and a renowned investor, stated in an interview with reporters that, given the ongoing population aging, he remains optimistic about the traditional Chinese medicine industry in the future, especially the long-term development of time-honored traditional Chinese medicine brands, and emphasized that he will continue to focus on high-quality and scarce targets
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments